about
Advances in pharmacological treatment of migraineRizatriptan in acute treatment of migraine: update on new comparative data.Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?Naratriptan: an alternative for migraine.Migraine: a comprehensive review of new treatment options.Acute migraine treatment outcome measures: a clinician's view.Drug comparisons: why are they so difficult?Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine.Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powderCommunicating the right therapy for the right patient at the right time: acute therapy.Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.Migraine is a neuronal disease.Where does a migraine attack originate? In the brainstem.Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study.Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study.Economic and patient-reported outcomes of oral triptans in the treatment of migraine.Differentiating the efficacy of 5-HT(1B/1D) agonists.Neuropeptide localization in the "migraine generator" region of the human brainstem.Patterns of ergotamine and sumatriptan use in the Netherlands from 1991 to 1997.Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.Is there a preferred triptan?[Which triptan is best? Rating of triptans in migraine treatment].Triptans in the treatment of migraine: drug selection by means of the SOJA method.Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study
P2860
Q28192002-2DB9B39B-8EBD-4F14-B673-A094AF968A2AQ30619774-8FFBCB7B-669C-4D6B-8A4E-64FA44621B00Q31893958-F76F9850-D3CF-4AAB-80B8-2F313319AAAAQ33689204-63BBACD9-B83A-4AD1-9973-34FB355E9EAAQ33715929-F98A6470-35D2-43D4-84CD-301DD8C53C95Q34155942-0972BDC6-EC2A-4DDC-B704-6900820A8746Q34155949-CAADC31F-2418-4C8D-A481-396762795EAAQ34505387-A9449B7B-3646-4E19-B797-959FA9868611Q34512817-260C5632-AB1E-4963-8C8B-E2004EBE66CCQ34760003-29AF886B-A1E6-4D80-B266-2A9FC8A2CE3EQ35750750-81F406E0-8E89-4B59-9832-0DBDAD512C3EQ37821333-15CEE1F3-07AD-4FBF-9C3A-3DF3DB16E44DQ37994597-5A49E43C-7C37-4E50-8D06-9DF086E1156FQ39401249-6529FC8F-D8CC-4D8D-9A37-9630237F0AA5Q39401929-6547DBF7-131B-4BC8-B5A9-DF4793474624Q40385073-8994B0C1-57A0-4053-9417-DD4C1168CA7FQ43551356-F680D0A0-3189-4B7B-B679-7F66C08FB045Q43650535-AEC6A65C-0A42-4A83-85C6-99EA0E47D788Q43687413-C162099A-9FB1-4153-B7A9-B43B6FF4E49AQ43969535-E63B8276-D4CD-4561-8EDD-AF37CE247234Q43989436-32572594-09E0-46B0-ACC1-D73B8D4202D5Q44171180-C1EB2530-74DD-424F-AE79-9914CC94E474Q46955158-DB4A475A-1D8C-4DF3-B955-21D6C32C88C2Q59045712-1B10D7D2-DB02-4BFE-BB5C-9DB5E1F860D2
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A triptan too far?
@en
type
label
A triptan too far?
@en
prefLabel
A triptan too far?
@en
P356
P1476
A triptan too far?
@en
P304
P356
10.1136/JNNP.64.2.143
P407
P577
1998-02-01T00:00:00Z